Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 4—April 2025
Research

Neutralizing Antibodies against California Serogroup Orthobunyaviruses in Human Serum Samples, Montana, USA

Tyson A. Woods1, Stephen F. Johnson1, Alyssa B. Evans2, and Karin E. PetersonComments to Author 
Author affiliation: Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA

Main Article

Table 3

Unbiased analysis of the 100 samples from east region in a study of neutralizing antibodies against California serogroup orthobunyaviruses in human serum samples, Montana, USA*

Viruses Neutralizing antibody titer dilution
>1,250 250 50 10†
Total no. samples
2
21
20
45
No. single positive‡
JCV 0 2 1 0
SSHV 0 0 0 0
LACV 0 9 1 0
CEV 1 2 2 2
TVTV 0 2 9 25
CVV
0
0
2
2
No. dual positive§
JCV + LACV 0 1 0 0
JCV + CEV 1 0 2 1
LACV + TVTV 0 2 1 0
CEV + TVTV 0 0 1 8
TVTV + CVV
0
0
0
4
No. triple positive¶ 0 3 1 3

*Highest titer of neutralization >50 for any California serogroup virus. CEV, California encephalitis virus; CVV, Cache Valley virus; E, East; JCV, James Canyon virus; LACV, La Crosse virus; NC, north central; NW, northwest; SC, south central; SSHV, snowshoe hare virus; SW, southwest; TVTV, Trivittatus virus. †Number detected only at 1:10 dilution. ‡Samples that had a 5× titer for 1 specific virus. §Samples with highest titer against 2 viruses. ¶Samples with highest titer against >2 viruses.

Main Article

1These first authors contributed equally to this article.

2Current affiliation: Department of Microbiology and Cell Biology, Montana State University, Bozeman, Montana, USA

Page created: February 08, 2025
Page updated: March 10, 2025
Page reviewed: March 10, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external